Abstract
Hyperlipidemia impacts millions of people globally and has been the major risk factor for developing atherosclerosis and cardiovascular disease. Interestingly, hyperlipidemic subjects exhibit increased incidence of rotator cuff tendon injury (RCTI) and disorganization of tendon matrix. Low-density lipoproteins (LDL) and its oxidized form (ox-LDL) play a crucial role in hyperlipidemia-driven pro-inflammatory responses in multiple tissues including the tendon. The signaling of oxLDL upregulates the inflammatory cytokines, chemokines, adhesion molecules, and the activation of monocytes/macrophages/resident tendon cells and matrix metalloproteinases impairing the tendon homeostasis resulting in the alteration of extracellular matrix. In addition, the hyperlipidemia-driven immune response and subsequent oxidative stress promote degenerative responses in the tendon tissue. However, the pathological mechanisms underlying the occurrence of RCTI in hyperlipidemia and the effect of ox-LDL in tendon matrix are currently unknown. The present review focuses on the implications and perspectives of LDL/oxLDL on the increased incidence of RCTI.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Hyperlipidemia is a chronic condition that describes various genetics and acquired disorders leading to elevated lipid levels in the body. Hyperlipidemia results in the increased risk of cardiovascular disease (CVD) as evident from the increased incidence at an early age (Balakumar 2016; Karr 2017). The advancements in medical sciences have benefitted the better management of hyperlipidemia and associated diseases. Moreover, the association of hyperlipidemia with musculoskeletal and tendon pathology has been documented (Yang et al. 2019). A seminal study reported that the patients with tendinopathy displayed increased level of circulatory cholesterol, LDL, and triglyceride with a concomitant reduction in HDL level suggesting the relationship between the two pathologies (Tilley et al. 2015); however, the underlying molecular mechanisms are obscure. Additionally, significant impairments in tendon integrity, structure, and biochemical makeup have been observed in patients with hyperlipidemia suggesting the increased prevalence of tendon injury or rupture (Soslowsky and Fryhofer 2016). Despite the clinical information, the pathological relationship between hyperlipidemia and tendon injuries is poorly understood at the molecular level. On this juncture, this review focuses on the cellular and biochemical mediators involved in the comorbidity of hyperlipidemia and rotator cuff tendon injury (RCTI) with an emphasis on LDL signaling.
Rotator cuff tendon injury (RCTI)
RCTI refers to musculoskeletal injuries relating to the coexistence of degeneration and inflammation in the rotator cuff (RC) tendon. Clinically, RCTI is presented as pain, inflammation, and inability of the shoulder to perform various ranges of motion especially elevation and external rotation (Lewis et al. 2015). Hence, RCTI has been the major musculoskeletal complaint in both clinical and sports medicine (Cools et al. 2015). Additional contributing factors, including smoking, age, and genetics, have been associated with the incidence of RCTI (Lädermann et al. 2015), (Li and Hua 2016). Biochemically, the RC tendons are composed of mostly water and collagen molecules embedded in the extracellular matrix (ECM) (Woo et al. 2008). In the ECM of RC tendon, the collagen is assembled into a hierarchical structure starting with fibrils that form fibers that associate with fascicles, and the bundles of fascicles constitute the fascicular matrix (Thorpe et al. 2015). Despite multiple cell types in the tendon tissues, the majority of the tendon is constituted of tenocytes, tenoblasts, and tendon stem/stromal cells (TSCs) (Kannus 2000). Roughly, 95% of the dry matter in the tendon tissue is type I collagen with varying amounts of collagen types III, V, XI, XII, and XIV (Table 1) (Screen et al. 2015; Thorpe et al. 2013). The type I collagen (Col-I) fibrils display stiff structures that provide mechanical durability and strength to the tendon tissue (Thankam et al. 2018a). Additionally, type II collagen (Col-II) only exists in small quantities which is typically concentrated near the tendon-bone insertion points (Kumagai et al. 1994). Moreover, the type III collagen (Col-III) fibrils are crucial in healing process and are upregulated following tendon injury. Hence, the presence of Col-III indicates an abnormal/healing response, resulting in elastic, loosely organized tissue (Maffulli et al. 2000). Importantly, the increased ratio of Col-III/Col-I in the tendon reflects degenerated tendon contributing to decreased mechanical resistance in RCTI (D'hondt et al. 2018).
Hyperlipidemia
Hyperlipidemia, obesity, and higher BMIs have been associated with disorganized collagen fibrils in the tendon tissue (Taş et al. 2017). The increased density of adipocytes in hyperlipidemia results in the increased pool of proinflammatory signals, hormones, and pathological mediators which influence multiple organs including the RC tendon (Bray et al. 2017). A seminal study involving 49,914 subjects reported the strong association of hyperlipidemia/obesity and the incidence, progression, and complications of RCTI compared to the control subjects (Macchi et al. 2020). Another study highlights that the patients with BMI > 75 reflected morphologically different tendon patterns of ECM organization compared to the subjects with lower BMI (Steinberg et al. 2020). In a recent study, it was demonstrated in a cohort of 5856 individuals that hypercholesterolemia (defined as total cholesterol greater than 5 mmol/L) increased risk of tendon injury in the upper extremities by 1.5-fold, and metabolic syndrome increased by 2.5-fold (Skovgaard et al. 2021). Moreover, influence of the changes in life style following the hyperlipidemic burden and subsequent statin therapy on tendon homeostasis is largely unknown warranting further research.
Low density lipoprotein
LDL is a complex lipoprotein containing various lipid species including triglycerides, phospholipids, and free/esterified cholesterol (Khosravi et al. 2018). Elevated levels of these plasma lipoproteins have been correlated with higher incidence of RCTI (Bolam et al. 2021; Longo et al. 2010). There are multiple pathways that promote the formation of oxidized LDL (oxLDL) which leads to increased levels of inflammatory cytokines, chemokines and adhesion molecules, activation of monocytes/macrophages and matrix metalloproteinase (MMPs), and upregulation of scavenger receptors (Steinberg 2009). Importantly, the subendothelial retention of native LDL and oxLDL triggers the infiltration and activation of inflammatory resulting in foam cell formation and the progression of atherosclerotic lesions (Ishigaki et al. 2009).
LDL particles circulate in the blood before binding to cell surface LDL receptors (LDL-R) which in turn mediate the cellular uptake of lipid components (Fig. 1) (Herz et al. 2000). The molecular events involve the binding of LDL particle on the plasma membrane, followed by internalization, and routing to the lysosome for degradation through a process called receptor-mediated endocytosis. Other family members in this receptor class include LDL-R, LDL receptor-related protein (LRP), megalin, very low-density lipoprotein receptors (VLDL-R), and ApoE receptor 2 (apoER2). The binding of structurally dissimilar ligands to these receptors results in the internalization in similar pathway (May et al. 2007). These receptors require Ca2+ for ligand binding.
The LDL-R is a cell surface glycoprotein comprised of 839 amino acids (Yamamoto et al. 1984) which is synthesized as an immature protein, processed in the Golgi apparatus, before turning into a mature form that is transported to the cell surface. LDL-R has an N-terminal ligand-binding domain consisting of seven cysteine rich complement type repeats. Additionally, it also contains 3 EGF precursor homology domains and one O-linked glycosylated domain (Hussain 2001). The entire receptor is rich in hydrophobic amino acid residues that promote membrane anchoring of cholesterol, while cytoplasmic membrane FDNPXY sequence is necessary for targeting of receptors. Studies have shown that the various repeats of negatively charged domains are necessary for a high binding affinity of cholesterol molecules; however, there is certain specificity that precludes all negatively (Goldstein et al. 1979). Specifically, the receptor binds apolipoprotein B (apoB) in LDL particles before being internalized by endocytosis via clathrin-coated pits involving the LDL receptor adaptor protein 1 (LDLRAP1) (Sniderman et al. 2010). After being endocytosed, the LDL molecule is degraded in an acidic lysosomal compartment and the cell receives LDL-derived cholesterol. This type of cholesterol further blocks sterol regulated membrane-bound transcription factors called sterol regulatory element-binding proteins (SREBPs). In cholesterol-depleted cells, SREBPs are normally synthesized in the endoplasmic reticulum, transported to the Golgi apparatus for processing, which activates the transcription of genes encoding HMG-CoA reductase (HMGCR) and the other enzymes of cholesterol biosynthesis and LDL receptor (Goldstein and Brown 2009). However, LDL-derived cholesterol blocks the transport to the Golgi, preventing the activation of HMGCR, to downregulate cholesterol synthesis, preventing cholesterol overload.
Low intracellular cholesterol levels trigger the activation of SREBPS to increase transcriptional activation of HMGCR (the rate limiting enzyme of cholesterol biosynthesis) and the downstream enzymes of the mevalonate (MVA) pathway (Sakakura et al. 2001). However, once the cell receives LDL-derived cholesterol, the transcription of the HMGCR gene is downregulated through the inactivation of the SREBP pathway via a feedback regulation. Additionally, the cholesterol content of the cell is regulated by the action of esterifying enzyme, acyl CoA:cholesterol acyltransferase (ACAT) and facilitating the storage (Kristiana et al. 2008).
The hyperlipidemia induces xanthomas (deposits of cholesterol in peripheral tissues) and accelerated atherosclerosis which increases risks of coronary heart disease. Xanthomas present as subcutaneous nodules with normal overlying skin and commonly occur on tendons, especially Achilles (Yang et al. 2019), tendon attachments, ligaments, fascia, and periosteum (Bell and Shreenath 2020). Mostly, the xanthomas appear in yellow color due to the presence of carotene found in lipids (Al Jasmi et al. 2019). Xanthomas cause pain, especially if localized on larger tendons, and lead to tendon rupture and weakness. Xanthomas bear cholesterol-rich materials and foams cells resulting from hyperlipidemia (Bath et al. 2010). There are rare cases of rotator cuff xanthomas reported; however, most of the pathology is found on the Achilles tendon. Hyperlipidemia normally leads to rotator cuff tears rather than xanthomas.
Native lipids (lipoproteins) do not induce foam cell formation; instead, the factors including the pathogenic modification of high local concentrations of lipids in connective tissue, the presence of qualitatively different lipoproteins at normal plasma lipid concentration, and increased extravasation of lipids, as well as dysfunction of the reverse cholesterol transport, are the key triggers (Zak et al. 2014). Typically, free cholesterol inhibits its de novo synthesis and the synthesis of LDL receptors. However, when phagocytic cells depend on the scavenger receptors [SR-A, SR-B1, CD36, lectin-like oxidized LDL receptor-1 (LOX-1)] for the uptake of oxidatively modified LDL particles, OxLDL (PrabhuDas et al. 2017). Interestingly, the oxLDL particles fail to activate the feedback receptors leading to a hyper-cholesterol environment, mediating the formation of xanthomas. Importantly, a positive relationship between the size of Achilles tendon xanthomas with titers of antibodies against OxLDL has been identified (Tsouli et al. 2005). Additionally, the decreased HDL concentration and disorders in the reverse cholesterol transport triggered the Achilles xanthomas despite normolipidemic subjects (Matsuura et al. 2005). Higher amounts of serum LDL have also been suggested to be responsible for the thickness of Achilles tendon, as well as RC tendinopathy, affecting the mechanical properties of the tendon and leading to higher rates of tendon injury (Scheel et al. 2004).
OxLDL
LDL undergoes biochemical modifications especially oxidation in the sub-endothelial space of the vascular wall. Oxidation of LDL is catalyzed by multiple reactions including a lipoxygenase reaction (Kühn et al. 1994; Sigal et al. 1994), metal mediated oxidation (Ehrenwald et al. 1994; Lynch and Frei 1993; Sakurai et al. 1991; Sniderman et al. 2010), and peroxidase catalyzed reactions (Napoli et al. 1991). LDL oxidation is a complex process where both the apolipoprotein B100 and lipids present in LDL are modified. Reactive oxygen species (ROS) induce fragmentation of apoB, producing peptides of varying sizes from 14 to 500 kDa as well as protein carbonyls (Matsuura et al. 2008). Additionally, lipids and fatty acids such as cholesteryl esters, phospholipids, and triglycerides present in LDL are susceptible to oxidation by ROS releasing free and esterified fatty acid peroxides, aldehydes, and ketones that are further oxidized to amplify the damage. The formation of these products or the changes in the properties of circulating LDL are not guaranteed during the oxidation of LDL as many are secondary products of oxidation and their formation largely depends on the type of oxidant, the extent of oxidation, and the presence or absence of other agents such as redox metals (Parthasarathy et al. 2010).
In blood vessels, oxLDL activates endothelial cells by triggering the expression of adhesion molecules (Obermayer et al. 2018) which mediate the rolling and adhesion of circulating leukocytes (monocytes and T cells) to the endothelium. Following adhesion, the monocytes migrate into the intimal layer in response to chemokines and subsequently differentiate into macrophages that upregulate both toll-like receptors (TLRs) and scavenger receptors (SRs) (Pirillo et al. 2013). Additionally, stimulation of membrane bound CD36, TLR2, TLR4, and TLR6 results in the upregulation of pro-inflammatory mediators and initiate immune activation of macrophages and microglia (Chávez-Sánchez et al. 2010; Stewart et al. 2010). As the consequence of the macrophage activation, proinflammatory cytokines are released, ROS are synthesized, and proteolytic enzymes are secreted contributing to the matrix degradation. However, activation of TLRs in tendinopathies is still under debate. However, TLR expression contributes minimally to Achilles tendon degeneration, but triggers degradative tissue reactions (de Mos et al. 2009). In contrast, our group reported that under an oxidative environment (oxidative stress) there is increased level of the major damage associated molecular patterns (DAMPS), high mobility group box (HMGB1), which in turn maintains RAGE, TLR4, and TLR2 in an activated state (Thankam et al. 2018b). In patients with RCTI and glenoid arthritis, HMGB1 was significantly upregulated contributing to the pro-inflammatory responses aggravating the injury. Additionally, the increased levels of HMGB1 and RAGE in patients with superior labral anterior to posterior (SLAP) tears are most likely due to the ischemia/necrosis-mediated sterile inflammation associated with the injury (Thankam et al. 2016). Interestingly, these DAMP mediators have been upregulated in the tendon tissues of RCTI rat model which were progressively downregulated during the course of healing (Thankam et al. 2018b).
Importantly, oxLDL has been identified as a ligand for receptors for advanced glycation end products (RAGE) in hyperlipidemic conditions (Sun et al. 2009). RAGE accelerates the lipid deposition and foam cell formation in smooth muscle cells by increasing the uptake of oxLDL, and the production of ROS with subsequent activation of NF-kB. NF-kB upregulates a battery of inflammatory mediators leading to chronic inflammatory state (Farmer and Kennedy 2009). Logically, this inflammatory pathway could be the link to explain tendinopathies caused by these molecules. Evidently, harvested human bicep tendons displayed significantly increased expression of HMGB1, RAGE, and angiogenesis in RCTI patients (Thankam et al. 2016). It has been hypothesized that these molecules contribute to increased cell migration and angiogenesis, resulting in the recruitment of additional inflammatory cells and release of mediators promoting ECM disorganization and eventual tendinosis (Fig. 2).
Additionally, oxLDL stimulates the polarization of macrophages to M2 phenotype, leading to increased IL-10 and transforming growth factor beta (TGF-β) (Rios et al. 2013). TGF-β precipitates fibrotic disorders leading to tendon injuries and stimulates the migration and proliferation of fibroblasts and ECM synthesis (Stone et al. 2016). Chronic elevation of TGF-β induces definitive changes in tendon ECM and tendon fibroblasts contributing to altered cellular responses to healing. However, TGF-β1 expression is known to be variable in diseased human tendons, depending on the anatomy of the tendon and its disease stage (tendinopathy or tear) (Fenwick et al. 2001; Goodier et al. 2016). Overall, the oxLDL causes significant pathophysiological tendon alterations, leading to a degradative phenotype.
Cholesterol in RCTI
Information from the animal models have suggested that higher serum concentrations of cholesterol favor the greater incidence of tendon pathology. High cholesterol-driven apoptosis and autophagy of Achilles tendon derived stem cells (TDSCs) through reactive oxygen species (ROS)-activated AKT/FOXO1 signaling have been reported suggesting the degenerative changes (Li et al. 2020) (Fig. 3). Moreover, cholesterol inhibits the proliferation and migration of tendon derived stem cells (TDSC) and induces cell cycle arrest. In a seminal study, the exposure of tendons to differing levels of cholesterol for varying amounts of time reduced the expression of Ki76, a proliferation marker, confirming an increase in cell cycle arrest (Beason et al. 2014) as evident from an increased proportion of G0/G1 phase cells and fewer G2/M and S phase cells. In addition, the increased cholesterol level significantly downregulated the expression of tendon cell markers with a simultaneous increase in ROS signaling via NF‐κB mediated pathway. As a result, significant histological alteration was evident in the experimental models with hypercholesterolemia (Li et al. 2019). Overall, high cholesterol inhibits tendon-related gene expression in TDSCs implying that pathogenesis in tendon injury is related to the alterations in tendon specific gene expression.
Apolipoprotein E (ApoE), the component of HDL, has been associated with its effects of alleviating pre-existing atherosclerotic lesions (Tangirala et al. 1999) as well as reducing LDL levels by promoting LDLR-dependent hepatic clearance of triglyceride-rich lipoproteins from the circulation (Rosenfeld et al. 1993). Interestingly, ApoE has been hypothesized to be protective for tendon function; however, the underlying mechanism is unknown. A recent study using ApoE knockout mice model reported that the consumption of a high-fat diet led to marked increase in oxLDL deposition in the load-bearing ECM of the tendon where the effect was aggravated in ApoE knockout group. Additionally, the lack of ApoE resulted in the increased pool of oxLDL and subsequent upregulation of matrix metalloproteinase 2 (MMP2) (Grewal et al. 2014). Similarly, another study reported an increase in the tendon stiffness and modulus in the supraspinatus tendons of hypercholesterolemic, ApoE knock-out mice, compared to control mice (Beason et al. 2011). Interestingly, a handful of reports concluded the impact of hypercholesterolemia in the pathogenesis of tendon injury. A summary of these studies is displayed in Table 2.
Abboud et al. (Abboud and Kim 2010) discovered that total cholesterol, triglycerides, and LDL-C levels were higher in patients with RCTI where HDL-C levels were lower than the control. In contrast, another study reported no significant difference between serum triglycerides and total serum cholesterol in RCTI (Longo et al. 2010). Also, a retrospective study found that patients prescribed for Achilles’ tendon repair surgery displayed increased levels of total cholesterol, LDL-C, and triglycerides with significant lipid deposits in tendon tissue compared to that of the healthy people (Wang et al. 2018). In addition, total cholesterol and LDL-C levels were significantly higher, while HDL-C levels were lower in patients with Achilles’ tendon repair than compared to controls (Ozgurtas et al. 2003). In a cross-sectional case-controlled study, patients with hyperlipidemia displayed significantly higher shear wave velocities in the patellar tendon indicating that the high levels of LDL impaired the biomechanical properties (Torgutalp et al. 2020). Interestingly, the LDL level had a direct impact on patellar tendon stiffness independently of body mass index. Similarly, hyperlipidemia and cholesterol accumulation were the major contributing factors to Achilles’ tendon injury in patients with familial hypercholesterolemia and tendinous xanthomas (Squier et al. 2021).
Importantly, the xanthoma formation has been associated with higher intracellular lipid content and higher inflammatory responses of macrophages to oxLDL. Therefore, xanthoma formation aggravates the risk of tendon inflammation due to abnormal inflammatory response and formation of macrophages (Artieda et al. 2005). Antibodies against oxLDL have been correlated with Achilles’ tendon thickness, and the patients demonstrated abnormal Achilles’ tendon echo structure with higher levels of oxLDL suggesting that immune cells from patients with familial hypercholesterolemia have increased predisposition to forming foam cells in the presence of oxLDL (Tsouli et al. 2006). In addition, there is significant association between moderate and high perioperative total cholesterol and LDL levels and the rates of repeat surgery after primary arthroscopic rotator cuff repair (Cancienne et al. 2017; Werner et al. 2017). This suggests that these elevated lipids also lead to rotator cuff pathological changes; however, further research is needed in this area. Overarchingly, the LDL levels correlate with the levels of oxLDL which eventually turn into tendinous xanthomas altering gross structure of the tendons. The intimate relationship between LDL and oxLDL and xanthomas cause tendons to increase in thickness and the thickness of the tendon returns closer to baseline following lowered levels of LDL (indirectly oxLDL) (Tsouli et al. 2005).
In the ApoE knockout mice group with the setting of a high fat diet, there was a significant increase in oxLDL levels in the load bearing parts of the tendon ECM. The ApoE knockout mice exhibited drastic decrease in tendon function and downregulation of Col IA1 genes compared to controls with increased MMP2 (Grewal et al. 2014).
Summary
Hyperlipidemia significantly alters the pathophysiology of tendon tissues; however, the exact underlying mechanisms are unclear. This critical review provides insights into potential link between the increased concentration of LDL and oxLDL in the bloodstream and tendon injury with an emphasis on RCTI. OxLDL signaling upregulates the inflammatory cytokines, chemokines, and adhesion molecules as well as activation of monocytes/macrophages and MMPs impairing the tendon homeostasis resulting in the alteration of ECM. In addition, the activated macrophages upregulate both toll-like receptors (TLRs) and scavenger receptors (SRs) leading to ROS generation and thus promoting degenerative responses. Furthermore, the upregulation of DAMPs including HMGB1 in hyperlipidemia and the downstream signaling enhances the overall pool of pro-inflammatory signals facilitating the aggravated co-morbidity of RCTI. Additionally, RAGE accelerates the lipid deposition and foam cell formation by increasing the uptake of oxLDL and the production of ROS with subsequent activation of NK-kB. NK-kB upregulates inflammatory mediators leading to chronic inflammatory state, leading to increased incidence of tendinopathies especially RCTI. Also, oxLDL stimulates the polarization of macrophages to M2 phenotype, leading to increased expression of IL-10 and TGF-β resulting in fibrotic disorders in the tendon. Overall, the hyperlipidemia affects almost every part of the body including the tendons; however, the information regarding the underlying molecular pathology is limited warranting further research. Moreover, the elucidation of the underlying molecular mechanisms and the targets to intervene could open multiple translational opportunities for the development of novel therapeutic strategies in the management of RCTI.
References
Abboud JA, Kim JS (2010) The effect of hypercholesterolemia on rotator cuff disease. Clin Orthop Relat Res® 468:1493–1497
Al Jasmi F, Galadari H, Clayton PT, Footitt EJ (2019) Metabolic disorders and the skin. Harper’s Textbook of Pediatric Dermatology 1965–1987
Artieda M, Cenarro A, Junquera C, Lasierra P, Martínez-Lorenzo MJ, Pocoví M, Civeira F (2005) Tendon xanthomas in familial hypercholesterolemia are associated with a differential inflammatory response of macrophages to oxidized LDL. FEBS Lett 579:4503–4512
Balakumar P, Maung-U K, Jagadeesh G (2016) Prevalence and prevention of cardiovascular disease and diabetes mellitus. Pharmacol Res 113:600–609
Bath SS, Bath S, Tehranzahdeh J (2010) Xanthomatous infiltration of the rotator cuff and long head of biceps with rotator cuff tear in a patient with mixed hyperlipidemia: a case report with MRI imaging. Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders 3:CMAMD. S3172
Beason DP, Abboud JA, Kuntz AF, Bassora R, Soslowsky LJ (2011) Cumulative effects of hypercholesterolemia on tendon biomechanics in a mouse model. J Orthop Res 29:380–383
Beason DP, Tucker JJ, Lee CS, Edelstein L, Abboud JA, Soslowsky LJ (2014) Rat rotator cuff tendon-to-bone healing properties are adversely affected by hypercholesterolemia. J Shoulder Elbow Surg 23:867–872
Bell A, Shreenath AP (2020) Xanthoma
Bolam SM, Park Y-E, Konar S, Callon KE, Workman J, Monk AP, Coleman B, Cornish J, Vickers MH, Munro JT (2021) Obesity impairs enthesis healing after rotator cuff repair in a rat model. Am J Sports Med 49:3959–3969
Bray G, Kim K, Wilding J (2017) F. World Obesity, Obesity: a chronic relapsing progressive disease process. A position statement of the World Obesity Federation. Obes Rev 18:715–723
Cancienne JM, Brockmeier SF, Rodeo SA, Werner BC (2017) Perioperative serum lipid status and statin use affect the revision surgery rate after arthroscopic rotator cuff repair. Am J Sports Med 45:2948–2954
Chávez-Sánchez L, Madrid-Miller A, Chávez-Rueda K, Legorreta-Haquet M, Tesoro-Cruz E, Blanco-Favela F (2010) Activation of TLR2 and TLR4 by minimally modified low-density lipoprotein in human macrophages and monocytes triggers the inflammatory response. Hum Immunol 71:737–744
Cools AM, Johansson FR, Borms D, Maenhout A (2015) Prevention of shoulder injuries in overhead athletes: a science-based approach. Braz J Phys Ther 00–00
D’hondt S, Guillemyn B, Syx D, Symoens S, De Rycke R, Vanhoutte L, Toussaint W, Lambrecht BN, De Paepe A, Keene DR, (2018) Type III collagen affects dermal and vascular collagen fibrillogenesis and tissue integrity in a mutant Col3a1 transgenic mouse model. Matrix Biol 70:72–83
de Mos M, Joosten LA, Oppers-Walgreen B, van Schie JT, Jahr H, van Osch GJ, Verhaar JA (2009) Tendon degeneration is not mediated by regulation of toll-like receptors 2 and 4 in human tenocytes. J Orthop Res 27:1043–1047
Ehrenwald E, Chisolm GM, Fox PL (1994) Intact human ceruloplasmin oxidatively modifies low density lipoprotein. J Clin Investig 93:1493–1501
Farmer DG, Kennedy S (2009) RAGE, vascular tone and vascular disease. Pharmacol Ther 124:185–194
Fenwick S, Curry V, Harrall R, Hazleman B, Hackney R, Riley G (2001) Expression of transforming growth factor-beta isoforms and their receptors in chronic tendinosis. The J Anat 199:231–240
Goldstein JL, Brown MS (2009) The LDL receptor. Arterioscler Thromb Vasc Biol 29:431–438
Goldstein JL, Ho Y, Basu SK, Brown MS (1979) Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci 76:333–337
Goodier HC, Carr AJ, Snelling SJ, Roche L, Wheway K, Watkins B, Dakin SG (2016) Comparison of transforming growth factor beta expression in healthy and diseased human tendon. Arthritis Res Ther 18:1–10
Grewal N, Thornton GM, Behzad H, Sharma A, Lu A, Zhang P, Reid WD, Granville DJ, Scott A (2014) Accumulation of oxidized LDL in the tendon tissues of C57BL/6 or apolipoprotein E knock-out mice that consume a high fat diet: potential impact on tendon health. PLoS One 9:e114214
Herz J, Gotthardt M, Willnow TE (2000) Cellular signalling by lipoprotein receptors. Curr Opin Lipidol 11:161–166
Hussain MM (2001) Structural, biochemical and signaling properties of the low-density lipoprotein receptor gene family. Front Biosci 6:D417–D428
Ishigaki Y, Oka Y, Katagiri H (2009) Circulating oxidized LDL: a biomarker and a pathogenic factor. Curr Opin Lipidol 20:363–369
Kannus P (2000) Structure of the tendon connective tissue. Scand J Med Sci Sports 10:312–320
Karr S (2017) Epidemiology and management of hyperlipidemia. Am J Manag Care 23:S139–S148
Khosravi M, Hosseini-Fard R, Najafi M (2018) Circulating low density lipoprotein (LDL). Horm Mol Biol Clin Investig 35
Kristiana I, Yang H, Brown AJ (2008) Different kinetics of cholesterol delivery to components of the cholesterol homeostatic machinery: implications for cholesterol trafficking to the endoplasmic reticulum. Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids 1781:724–730
Kühn H, Belkner J, Suzuki H, Yamamoto S (1994) Oxidative modification of human lipoproteins by lipoxygenases of different positional specificities. J Lipid Res 35:1749–1759
Kumagai J, Sarkar K, Uhthoff HK, Okawara Y, Ooshima A (1994) Immunohistochemical distribution of type I, II and III collagens in the rabbit supraspinatus tendon insertion. J Anat 185:279
Lädermann A, Denard PJ, Collin P (2015) Massive rotator cuff tears: definition and treatment. Int Orthop 39:2403–2414
Lewis J, McCreesh K, Roy J-S, Ginn K (2015) Rotator cuff tendinopathy: navigating the diagnosis-management conundrum. J Orthop Sports Phys Ther 45:923–937
Li H-Y, Hua Y-H (2016) Achilles tendinopathy: current concepts about the basic science and clinical treatments. Bioed Res Int 2016
Li K, Deng G, Deng Y, Chen S, Wu H, Cheng C, Zhang X, Yu B, Zhang K (2019) High cholesterol inhibits tendon-related gene expressions in tendon-derived stem cells through reactive oxygen species-activated nuclear factor-κB signaling. J Cell Physiol 234:18017–18028
Li K, Deng Y, Deng G, Chen P, Wang Y, Wu H, Ji Z, Yao Z, Zhang X, Yu B (2020) High cholesterol induces apoptosis and autophagy through the ROS-activated AKT/FOXO1 pathway in tendon-derived stem cells. Stem Cell Res Ther 11:1–16
Longo UG, Franceschi F, Spiezia F, Forriol F, Maffulli N, Denaro V (2010) Triglycerides and total serum cholesterol in rotator cuff tears: do they matter? Br J Sports Med 44:948–951
Lynch SM, Frei B (1993) Mechanisms of copper-and iron-dependent oxidative modification of human low density lipoprotein. J Lipid Res 34:1745–1753
Macchi M, Spezia M, Elli S, Schiaffini G, Chisari E (2020) Obesity increases the risk of tendinopathy, tendon tear and rupture, and postoperative complications: a systematic review of clinical studies. Clin Orthop Relat Res® 478:1839–1847
Maffulli N, Ewen SW, Waterston SW, Reaper J, Barrass V (2000) Tenocytes from ruptured and tendinopathic achilles tendons produce greater quantities of type III collagen than tenocytes from normal achilles tendons: an in vitro model of human tendon healing. Am J Sports Med 28:499–505
Matsuura E, Hughes GR, Khamashta MA (2008) Oxidation of LDL and its clinical implication. Autoimmun Rev 7:558–566
Matsuura F, Hirano K-i, Koseki M, Ohama T, Matsuyama A, Tsujii K-i, Komuro R, Nishida M, Sakai N, Hiraoka H (2005) Familial massive tendon xanthomatosis with decreased high-density lipoprotein–mediated cholesterol efflux. Metab 54:1095–1101
May P, Woldt E, Matz RL, Boucher P (2007) The LDL receptor-related protein (LRP) family: an old family of proteins with new physiological functions. Ann Med 39:219–228
Napoli C, Ambrosio G, Palumbo G, Elia P, Chiariello M (1991) Human low-density lipoproteins are peroxidized by free radicals via chain reactions triggered by the superoxide radical. Cardiologia (rome, Italy) 36:527–532
Obermayer G, Afonyushkin T, Binder C (2018) Oxidized low-density lipoprotein in inflammation-driven thrombosis. J Thromb Haemost 16:418–428
Oosterveer DM, Versmissen J, Yazdanpanah M, Defesche JC, Kastelein JJ, Sijbrands EJ (2010) The risk of tendon xanthomas in familial hypercholesterolaemia is influenced by variation in genes of the reverse cholesterol transport pathway and the low-density lipoprotein oxidation pathway. Eur Heart J 31:1007–1012
Ozgurtas T, Yildiz C, Serdar M, Atesalp S, Kutluay T (2003) Is high concentration of serum lipids a risk factor for Achilles tendon rupture? Clin Chim Acta 331:25–28
Parthasarathy S, Raghavamenon A, Garelnabi MO, Santanam N (2010) Oxidized low-density lipoprotein. Free Radic Antioxid Prot 403–417
Pirillo A, Norata GD, Catapano AL (2013) LOX-1, OxLDL, and atherosclerosis. Mediators Inflamm 2013
PrabhuDas MR, Baldwin CL, Bollyky PL, Bowdish DM, Drickamer K, Febbraio M, Herz J, Kobzik L, Krieger M, Loike J (2017) A consensus definitive classification of scavenger receptors and their roles in health and disease. J Immunol 198:3775–3789
Rios FJ, Koga MM, Pecenin M, Ferracini M, Gidlund M, Jancar S (2013) Oxidized LDL induces alternative macrophage phenotype through activation of CD36 and PAFR. Mediators Inflamm 2013
Rosenfeld ME, Butler S, Ord VA, Lipton BA, Dyer CA, Curtiss LK, Palinski W, Witztum JL (1993) Abundant expression of apoprotein E by macrophages in human and rabbit atherosclerotic lesions. Arterioscler Thromb: J Vasc Biol 13:1382–1389
Sakakura Y, Shimano H, Sone H, Takahashi A, Inoue K, Toyoshima H, Suzuki S, Yamada N (2001) Sterol regulatory element-binding proteins induce an entire pathway of cholesterol synthesis. Biochem Biophys Res Commun 286:176–183
Sakurai T, Kimura S, Nakano M, Kimura H (1991) Oxidative modification of glycated low density lipoprotein in the presence of iron. Biochem Biophys Res Commun 177:433–439
Scheel AK, Schettler V, Koziolek M, Koelling S, Werner C, Müller GA, Strutz F (2004) Impact of chronic LDL-apheresis treatment on Achilles tendon affection in patients with severe familial hypercholesterolemia: a clinical and ultrasonographic 3-year follow-up study. Atherosclerosis 174:133–139
Screen HR, Berk DE, Kadler KE, Ramirez F, Young MF (2015) Tendon functional extracellular matrix. J Orthop Res 33:793–799
Sigal E, Laughton CW, Mulkins MA (1994) Oxidation, lipoxygenase, and atherogenesis. Ann N Y Acad Sci 714:211–224
Skovgaard D, Siersma VD, Klausen SB, Visnes H, Haukenes I, Bang CW, Bager P, Grävare Silbernagel K, Gaida J, Magnusson SP (2021) Chronic hyperglycemia, hypercholesterolemia, and metabolic syndrome are associated with risk of tendon injury. Scand J Med Sci Sports 31:1822–1831
Sniderman AD, De Graaf J, Couture P, Williams K, Kiss RS, Watts GF (2010) Regulation of plasma LDL: the apoB paradigm. Clin Sci 118:333–339
Soslowsky LJ, Fryhofer GW (2016) Tendon homeostasis in hypercholesterolemia. Metabolic Influences on Risk for Tendon Disorders 151–165
Squier K, Scott A, Hunt MA, Brunham LR, Wilson DR, Screen H, Waugh CM (2021) The effects of cholesterol accumulation on Achilles tendon biomechanics: A cross-sectional study. PLoS ONE 16:e0257269
Steinberg D (2009) The LDL modification hypothesis of atherogenesis: an update. J Lipid Res 50:S376–S381
Steinberg N, Eliakim A, Elbaz L, Pantanowitz M, Zeev A, Nemet D (2020) Achilles tendon tissue structure in children with overweight and children with obesity. Phys Occup Ther Pediatr 40:330–344
Stewart CR, Stuart LM, Wilkinson K, Van Gils JM, Deng J, Halle A, Rayner KJ, Boyer L, Zhong R, Frazier WA (2010) CD36 ligands promote sterile inflammation through assembly of a toll-like receptor 4 and 6 heterodimer. Nat Immunol 11:155–161
Stone RC, Pastar I, Ojeh N, Chen V, Liu S, Garzon KI, Tomic-Canic M (2016) Epithelial-mesenchymal transition in tissue repair and fibrosis. Cell Tissue Res 365:495–506
Sun L, Ishida T, Yasuda T, Kojima Y, Honjo T, Yamamoto Y, Yamamoto H, Ishibashi S, Hirata K-i, Hayashi Y (2009) RAGE mediates oxidized LDL-induced pro-inflammatory effects and atherosclerosis in non-diabetic LDL receptor-deficient mice. Cardiovasc Res 82:371–381
Tangirala RK, Tsukamoto K, Chun SH, Usher D, Puré E, Rader DJ (1999) Regression of atherosclerosis induced by liver-directed gene transfer of apolipoprotein AI in mice. Circulation 100:1816–1822
Taş S, Yılmaz S, Onur MR, Soylu AR, Altuntaş O, Korkusuz F (2017) Patellar tendon mechanical properties change with gender, body mass index and quadriceps femoris muscle strength. Acta Orthop Traumatol Turc 51:54–59
Thankam FG, Dilisio MF, Dietz NE, Agrawal DK (2016) TREM-1, HMGB1 and RAGE in the shoulder tendon: dual mechanisms for inflammation based on the coincidence of glenohumeral arthritis. PLoS ONE 11:e0165492
Thankam FG, Dilisio MF, Gross RM, Agrawal DK (2018a) Collagen I: a kingpin for rotator cuff tendon pathology. Am J Transl Res 10:3291
Thankam FG, Roesch ZK, Dilisio MF, Radwan MM, Kovilam A, Gross RM, Agrawal DK (2018b) Association of inflammatory responses and ECM disorganization with HMGB1 upregulation and NLRP3 inflammasome activation in the injured rotator cuff tendon. Sci Rep 8:1–14
Thorpe CT, Birch HL, Clegg PD, Screen HR (2013) The role of the non-collagenous matrix in tendon function. Int J Exp Pathol 94:248–259
Thorpe CT, Birch HL, Clegg PD, Screen HR (2015) Tendon physiology and mechanical behavior: structure–function relationships. Tendon Regeneration. Elsevier 3–39
Tilley BJ, Cook JL, Docking SI, Gaida JE (2015) Is higher serum cholesterol associated with altered tendon structure or tendon pain? A systematic review. Br J Sports Med 49:1504–1509
Torgutalp ŞŞ, Babayeva N, Taş S, Dönmez G, Korkusuz F (2020) Effects of hyperlipidemia on patellar tendon stiffness: a shear wave elastography study. Clin Biomech 75:104998
Tsouli S, Kiortsis D, Argyropoulou M, Mikhailidis D, Elisaf M (2005) Pathogenesis, detection and treatment of Achilles tendon xanthomas. Eur J Clin Invest 35:236–244
Tsouli SG, Kiortsis DN, Lourida ES, Xydis V, Tsironis LD, Argyropoulou MI, Elisaf M, Tselepis AD (2006) Autoantibody titers against OxLDL are correlated with Achilles tendon thickness in patients with familial hypercholesterolemia. J Lipid Res 47:2208–2214
Wang B, Zhang Q, Lin L, Pan L-l, He C-y, Wan X-x, Zheng Z-a, Huang Z-x, Zou C-b, Fu M-c (2018) Association of Achilles tendon thickness and LDL-cholesterol levels in patients with hypercholesterolemia. Lipids Health Dis 17:1–7
Werner B, Cancienne J, Brockmeier S, Rodeo S (2017) Perioperative serum lipid status and statin use affect revision surgery rate after arthroscopic rotator cuff repair. Arthroscopy 33:e26
Woo SL, Fisher MB, Feola AJ (2008) Contribution of biomechanics to management of ligament and tendon injuries. Mol Cell Biomech 5:49
Yamamoto T, Davis CG, Brown MS, Schneider WJ, Casey ML, Goldstein JL, Russell DW (1984) The human LDL receptor: a cysteine-rich protein with multiple Alu sequences in its mRNA. Cell 39:27–38
Yang Y, Lu H, Qu J (2019) Tendon pathology in hypercholesterolaemia patients: epidemiology, pathogenesis and management. J Orthop Translat 16:14–22
Yang Y-P, Tao L-Y, Gao J-N, Wang P, Jiang Y-F, Zheng L-M, Zhao Y-M, Ao Y-F (2020) Elevated lipid levels in patients with Achilles tendon ruptures: a retrospective matching study. Ann Transl Med 8
Zak A, Zeman M, Slaby A, Vecka M (2014) Xanthomas: clinical and pathophysiological relations. Biomedical Papers of the Medical Faculty of Palacky University in Olomouc 158
Acknowledgements
FGT is thankful to WesternU for the startup funds, and DKA is grateful to National Institutes of Health, USA, for funding.
Funding
Open access funding provided by SCELC, Statewide California Electronic Library Consortium The research work of FGT is supported by the startup funds from WesternU. DK Agrawal is supported by research grants R01HL144125 and R01HL147662 from the National Institutes of Health, USA.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical approval
Not applicable.
Consent to participate
Not applicable.
Consent for publication
All the authors have read the manuscript and consented for publication.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Fang, W.H., Bonavida, V., Agrawal, D.K. et al. Hyperlipidemia in tendon injury: chronicles of low-density lipoproteins. Cell Tissue Res 392, 431–442 (2023). https://doi.org/10.1007/s00441-023-03748-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00441-023-03748-8